Skip to main content
Rafael Holdings, Inc. logo

Rafael Holdings, Inc. — Investor Relations & Filings

Ticker · RFL ISIN · US75062C1009 US Professional, scientific and technical activities
Open in API
Filings indexed 393 across all filing types
Latest filing 2024-12-23 Director's Dealing
Country US United States of America
Listing US RFL

About Rafael Holdings, Inc.

https://rafaelholdings.com

Rafael Holdings, Inc. is a clinical-stage biotechnology company that invests in and develops therapies for difficult-to-treat diseases. The company holds interests in early-stage and clinical pharmaceutical entities, with a primary focus on novel cancer therapeutics aimed at improving and extending the lives of patients. Following a merger with Cyclo Therapeutics, Rafael Holdings is also advancing a potential breakthrough treatment for Niemann-Pick Type C1, a rare genetic disorder.

Recent filings

Filing Released Lang Actions
4
Director's Dealing
2024-12-23 English
REGISTRATION STATEMENT
Merger & Acquisition Classification · 100% confidence The document is a Form S-4/A Registration Statement filed with the SEC, dated December 19, 2024, related to a merger transaction between Rafael Holdings, Inc. and Cyclo Therapeutics, Inc. It includes detailed information about the merger agreement, exchange ratio, stockholder meetings, and proxy statements. The presence of a joint proxy statement/prospectus and detailed merger terms indicates this is a filing related to merger and acquisition activity. The document is not a simple announcement or a proxy solicitation alone but a comprehensive registration statement for securities issued in connection with the merger. Therefore, the appropriate classification is 'Merger & Acquisition' (MA).
2024-12-20 English
Regulatory Filings 2024
Regulatory Filings Classification · 95% confidence The document is a detailed correspondence letter addressed to the SEC regarding an Amendment No. 1 to a Registration Statement on Form S-4 filed by Rafael Holdings, Inc. It includes responses to SEC staff comments on disclosures related to a merger transaction, clinical trial data, regulatory compliance, and other detailed business and financial disclosures. The document references the Registration Statement on Form S-4, which is used for securities registration in connection with mergers and acquisitions. The content focuses on merger-related disclosures, regulatory compliance, and clarifications about clinical trials and business operations post-merger. This is not a full annual report, earnings release, or other financial report but rather a regulatory filing responding to SEC comments on a merger registration statement. Therefore, the document best fits the category of Regulatory Filings (RNS), as it is a detailed regulatory correspondence that does not constitute the actual merger proxy statement or registration statement itself but is part of the regulatory review process.
2024-12-20 English
Regulatory Filings 2024
Regulatory Filings Classification · 95% confidence The document is a letter from Rafael Holdings, Inc. to the SEC Division of Corporation Finance responding to comments on the company's Form 10-K for the fiscal year ended July 31, 2024. It references specific pages and disclosures within the Form 10-K, discusses amendments to the Form 10-K, and addresses regulatory comments on business descriptions, clinical trial disclosures, risk factors, and financial statement notes. The letter is clearly related to the Form 10-K filing and is not the Form 10-K report itself but a correspondence regarding amendments to it. However, the document length (12,841 characters) and detailed responses indicate it is not a brief announcement or certification but a substantive regulatory correspondence. Given the content and context, this document is best classified as a Regulatory Filing (RNS) because it is a response letter to the SEC staff comments on the Form 10-K, not the Form 10-K report itself.
2024-12-20 English
AMENDMENT NO. 1 TO FORM 10-K
Annual Report FY 2024
2024-12-20 English
Regulatory Filings 2024
Regulatory Filings
2024-12-12 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.